获取技术与外部支架对冠状动脉旁路移植术后2年静脉移植物病变进展的影响
VEST III试验的事后分析,183例冠状动脉旁路移植患者中开放获取126例(252根大隐静脉移植物)、内镜获取57例(114根)。开放获取较内镜获取在6个月和2年总体通畅率更高,且减少内膜增生;外部支架可减少静脉移植物病变进展,尤其在开放获取组。
要点
- 开放获取较内镜获取6个月总体通畅率92.9% vs 80.4%(P=0.04),2年90.8% vs 73.9%(P=0.01)。
- 开放获取较内镜获取内膜增生面积减少31.8%(P=0.04),厚度减少28.9%(P=0.04)。
- 外部支架在开放获取组改善Fitzgibbon通畅率(OR 2.84,P=0.01),减少内膜增生面积19.5%(P<0.001)。
核心结论
- VEST III试验的事后分析显示,开放获取与更好的总体大隐静脉移植物通畅率和更少的内膜增生相关。
- 外部支架可减少大隐静脉移植物病变进展,尤其在开放获取时。
研究设计与样本
- VEST III试验的事后分析,评估183例冠状动脉旁路移植患者,开放获取126例(252根大隐静脉移植物),内镜获取57例(114根大隐静脉移植物)。
- 6个月时通过计算机断层扫描血管造影评估总体通畅率,2年时通过冠状动脉造影评估;2年时通过冠状动脉造影评估Fitzgibbon通畅分级,通过血管内超声在部分患者中评估内膜增生。
主要发现
- 开放获取较内镜获取6个月总体大隐静脉移植物通畅率92.9% vs 80.4%(P=0.04),2年90.8% vs 73.9%(P=0.01)。
- 开放获取较内镜获取Fitzgibbon I、II、III级分别为65.2% vs 49.2%、25.3% vs 45.9%、9.5% vs 4.9%(OR 2.81,P=0.09)。
- 开放获取较内镜获取内膜增生面积减少31.8%(P=0.04),厚度减少28.9%(P=0.04)。
- 外部支架在开放获取组改善Fitzgibbon通畅率(OR 2.84,P=0.01),减少内膜增生面积19.5%(P<0.001)和厚度25.0%(P<0.001)。
- 外部支架在内镜获取组减少内膜增生面积12.7%(P=0.01),厚度减少9.5%(P=0.21)。
关键数值与推荐
- 开放获取较内镜获取6个月总体通畅率92.9% vs 80.4%(P=0.04),2年90.8% vs 73.9%(P=0.01)。
- 开放获取较内镜获取Fitzgibbon I、II、III级分别为65.2% vs 49.2%、25.3% vs 45.9%、9.5% vs 4.9%(OR 2.81,P=0.09)。
- 开放获取较内镜获取内膜增生面积减少31.8%(P=0.04),厚度减少28.9%(P=0.04)。
- 外部支架在开放获取组Fitzgibbon通畅率OR 2.84(P=0.01),内膜增生面积减少19.5%(P<0.001),厚度减少25.0%(P<0.001)。
- 外部支架在内镜获取组内膜增生面积减少12.7%(P=0.01),厚度减少9.5%(P=0.21)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In a post hoc analysis of the VEST III trial, we investigated the effect of the harvesting technique on saphenous vein graft (SVG) patency and disease progression after coronary artery bypass grafting. METHODS: Angiographic outcomes were assessed in 183 patients undergoing open (126 patients, 252 SVG) or endoscopic harvesting (57 patients, 114 SVG). Overall SVG patency was assessed by computed tomography angiography at 6 months and by coronary angiography at 2 years. Fitzgibbon patency (FP I, II and III) and intimal hyperplasia (IH) in a patient subset were assessed by coronary angiography and intravascular ultrasound, respectively, at 2 years. RESULTS: Baseline characteristics were similar between patients who underwent open and those who underwent endoscopic harvesting. Open compared with endoscopic harvesting was associated with higher overall SVG patency rates at 6 months (92.9% vs 80.4%, P = 0.04) and 2 years (90.8% vs 73.9%, P = 0.01), improved FP I, II and III rates (65.2% vs 49.2%; 25.3% vs 45.9%, and 9.5% vs 4.9%, respectively; odds ratio 2.81, P = 0.09) and reduced IH area (-31.8%; P = 0.04) and thickness (-28.9%; P = 0.04). External stenting was associated with improved FP I, II and III rates (odds ratio 2.84, P = 0.01), reduced IH area (-19.5%; P < 0.001) and thickness (-25.0%; P < 0.001) in the open-harvest group and reduced IH area (-12.7%; P = 0.01) and thickness (-9.5%; P = 0.21) in the endoscopic-harvest group. CONCLUSIONS: A post-hoc analysis of the VEST III trial showed that open harvesting is associated with improved overall SVG patency and reduced IH. External stenting reduces SVG disease progression, particularly with open harvesting.
引用
- Sandner SE, Donovan TJ, Edelstein S, et al. Effects of the harvesting technique and external stenting on progression of vein graft disease 2 years after coronary artery bypass. Eur J Cardiothorac Surg. 2022. PMID: 35312782. doi:10.1093/ejcts/ezac045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。